These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 35081689)
1. Syntaxin 5 determines Weibel-Palade body size and von Willebrand factor secretion by controlling Golgi architecture. Kat M; Karampini E; Hoogendijk AJ; Bürgisser PE; Mulder AA; Van Alphen FPJ; Olins J; Geerts D; Van den Biggelaar M; Margadant C; Voorberg J; Bierings R Haematologica; 2022 Aug; 107(8):1827-1839. PubMed ID: 35081689 [TBL] [Abstract][Full Text] [Related]
3. Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells. Schillemans M; Karampini E; van den Eshof BL; Gangaev A; Hofman M; van Breevoort D; Meems H; Janssen H; Mulder AA; Jost CR; Escher JC; Adam R; Carter T; Koster AJ; van den Biggelaar M; Voorberg J; Bierings R Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1549-1561. PubMed ID: 29880488 [TBL] [Abstract][Full Text] [Related]
4. Interaction networks of Weibel-Palade body regulators syntaxin-3 and syntaxin binding protein 5 in endothelial cells. Schillemans M; Karampini E; Hoogendijk AJ; Wahedi M; van Alphen FPJ; van den Biggelaar M; Voorberg J; Bierings R J Proteomics; 2019 Aug; 205():103417. PubMed ID: 31201948 [TBL] [Abstract][Full Text] [Related]
5. Proximity proteomics of endothelial Weibel-Palade bodies identifies novel regulator of von Willebrand factor secretion. Holthenrich A; Drexler HCA; Chehab T; Naß J; Gerke V Blood; 2019 Sep; 134(12):979-982. PubMed ID: 31262780 [TBL] [Abstract][Full Text] [Related]
6. STXBP1 promotes Weibel-Palade body exocytosis through its interaction with the Rab27A effector Slp4-a. van Breevoort D; Snijders AP; Hellen N; Weckhuysen S; van Hooren KW; Eikenboom J; Valentijn K; Fernandez-Borja M; Ceulemans B; De Jonghe P; Voorberg J; Hannah M; Carter T; Bierings R Blood; 2014 May; 123(20):3185-94. PubMed ID: 24700782 [TBL] [Abstract][Full Text] [Related]
7. VAMP3 is associated with endothelial weibel-palade bodies and participates in their Ca(2+)-dependent exocytosis. Pulido IR; Jahn R; Gerke V Biochim Biophys Acta; 2011 May; 1813(5):1038-44. PubMed ID: 21094665 [TBL] [Abstract][Full Text] [Related]
8. Temperature-dependence of Weibel-Palade body exocytosis and cell surface dispersal of von Willebrand factor and its propolypeptide. Hewlett L; Zupančič G; Mashanov G; Knipe L; Ogden D; Hannah MJ; Carter T PLoS One; 2011; 6(11):e27314. PubMed ID: 22096550 [TBL] [Abstract][Full Text] [Related]
9. Tuning the endothelial response: differential release of exocytic cargos from Weibel-Palade bodies. Nightingale TD; McCormack JJ; Grimes W; Robinson C; Lopes da Silva M; White IJ; Vaughan A; Cramer LP; Cutler DF J Thromb Haemost; 2018 Sep; 16(9):1873-1886. PubMed ID: 29956444 [TBL] [Abstract][Full Text] [Related]
10. Type II PI4-kinases control Weibel-Palade body biogenesis and von Willebrand factor structure in human endothelial cells. Lopes da Silva M; O'Connor MN; Kriston-Vizi J; White IJ; Al-Shawi R; Simons JP; Mössinger J; Haucke V; Cutler DF J Cell Sci; 2016 May; 129(10):2096-105. PubMed ID: 27068535 [TBL] [Abstract][Full Text] [Related]
11. How to roll an endothelial cigar: the biogenesis of Weibel-Palade bodies. Michaux G; Cutler DF Traffic; 2004 Feb; 5(2):69-78. PubMed ID: 14690496 [TBL] [Abstract][Full Text] [Related]
12. VWF maturation and release are controlled by 2 regulators of Weibel-Palade body biogenesis: exocyst and BLOC-2. Sharda AV; Barr AM; Harrison JA; Wilkie AR; Fang C; Mendez LM; Ghiran IC; Italiano JE; Flaumenhaft R Blood; 2020 Dec; 136(24):2824-2837. PubMed ID: 32614949 [TBL] [Abstract][Full Text] [Related]
13. Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies. Bouwens EA; Mourik MJ; van den Biggelaar M; Eikenboom JC; Voorberg J; Valentijn KM; Mertens K Blood; 2011 Nov; 118(22):5947-56. PubMed ID: 21940821 [TBL] [Abstract][Full Text] [Related]
14. Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells. Hannah MJ; Skehel P; Erent M; Knipe L; Ogden D; Carter T J Biol Chem; 2005 Jun; 280(24):22827-30. PubMed ID: 15831502 [TBL] [Abstract][Full Text] [Related]
15. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response. Kat M; Margadant C; Voorberg J; Bierings R FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944 [TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention. Yadegari H; Biswas A; Ahmed S; Naz A; Oldenburg J Hum Mutat; 2021 Jun; 42(6):731-744. PubMed ID: 33942438 [TBL] [Abstract][Full Text] [Related]
17. Emerging mechanisms to modulate VWF release from endothelial cells. El-Mansi S; Nightingale TD Int J Biochem Cell Biol; 2021 Feb; 131():105900. PubMed ID: 33301925 [TBL] [Abstract][Full Text] [Related]
18. Mutations in Neurobeachin-like 2 do not impact Weibel-Palade body biogenesis and von Willebrand factor secretion in gray platelet syndrome Endothelial Colony Forming Cells. Kat M; van Moort I; Bürgisser PE; Kuijpers TW; Hofman M; Favier M; Favier R; Margadant C; Voorberg J; Bierings R Res Pract Thromb Haemost; 2023 Feb; 7(2):100086. PubMed ID: 36923710 [TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor binds to angiopoietin-2 within endothelial cells and after release from Weibel-Palade bodies. Mobayen G; Smith K; Ediriwickrema K; Starke RD; Solomonidis EG; Laffan MA; Randi AM; McKinnon TAJ J Thromb Haemost; 2023 Jul; 21(7):1802-1812. PubMed ID: 37011710 [TBL] [Abstract][Full Text] [Related]
20. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation. Castaman G; Giacomelli SH; Jacobi PM; Obser T; Budde U; Rodeghiero F; Schneppenheim R; Haberichter SL J Thromb Haemost; 2012 May; 10(5):951-8. PubMed ID: 22429825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]